Siga Technologies Inc (SIGAQ) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Jun 30 2018 - CSIMarket
CSIMarket
 


Siga Technologies Inc  (SIGAQ)

Siga Technologies Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Siga Technologies Inc in the fourth quarter 2019?
Siga Technologies Inc achieved a return on average equity (ROE) of 425.35 % in its fourth quarter 2019, this is above SIGAQ's average return on equity of -8.12%.
Siga Technologies Inc shareholder's equity over the 12 months ending in its fourth quarter 2019 are valued at $89 million

While the company's net income was fading, Siga Technologies Inc was able to improve its ROE compared to the third quarter 2019.

Within the Major Pharmaceutical Preparations industry 73 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the third quarter 2019 at no. .

What is ROE?




Return On Equity (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 379 377 366 360 -39
Return On Equity (TTM) 425.35 % - - - -
SIGAQ's Total Ranking # # # # #
Equity (TTM) in Millions 98 103 103 52 -341
Seq. Equity Change -4.94 % -0.57 % 97.15 % - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 74
Sector # 219
Overall #

Return On Equity Statistics
High Average Low
-8.12 %
-8.12 %
-8.12 %
(Dec 31 2019)  





SIGAQ Annual Return On Equity (Dec 31 2019)
2019




Total Equity in Millions 98 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -7 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -7.41 % - - - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SIGAQ's' Return on Equity at Yahoo Finance
SIGAQ's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SIGAQ's Competitors
Subscribers only: Roe for Siga Technologies Inc's Suppliers
Subscribers only: Return On Equity for SIGAQ's Customers




Companies with similar Return On Equity at Dec 31 2019, within Healthcare Sector ROE
Zomedica Corp   611.96 %
Tuhura Biosciences Inc   497.74 %
Lexicon Pharmaceuticals Inc   303.98 %
Coherus Oncology inc   302.63 %
Xbiotech Inc   288.62 %
Eli Lilly And Company  287.25 %
Idexx Laboratories Inc  283.32 %
Quoin Pharmaceuticals Ltd   232.48 %
Aveo Pharmaceuticals Inc   225.40 %
Check Cap Ltd  221.94 %
Morphic Holding inc   212.35 %
Orgenesis Inc   183.75 %
Waters Corporation  166.44 %
Semler Scientific inc   152.53 %
Integrated Biopharma Inc  117.48 %
Nrc Health  117.23 %
Mettler toledo International Inc   116.60 %
Tenax Therapeutics Inc   114.72 %
Surgalign Holdings Inc   113.88 %
Altamira Therapeutics Ltd   107.01 %


Date modified: 2026-09-26T08:35:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.